Inventor · disambiguated record
Reinhard Brueckner
Also filed as: BRUECKNER REINHARD
18 granted patents·1 pending application·87 citations·filing 1995–2009
93Inventor score
Top patents by PatentIndex Score
19 records- 0180US7368582B2Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2004·Granted May 6, 2008·11 cites·11 claims
- 0275US6602880B23-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmiaSOLVAY PHARM GMBH·Filed 2002·Granted Aug 5, 2003·7 cites·8 claims
- 0373US7767692B21-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compoundsSOLVAY PHARM GMBH·Filed 2003·Granted Aug 3, 2010·7 cites·40 claims
- 0472US6407106B1N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activitySOLVAY PHARM GMBH·Filed 2001·Granted Jun 18, 2002·7 cites·8 claims
- 0567US5547967A(Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing themKALI CHEMIE PHARMA GMBH·Filed 1995·Granted Aug 20, 1996·13 cites·12 claims
- 0664US6770649B21-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2002·Granted Aug 3, 2004·2 cites·12 claims
- 0762US7534903B2Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease statesSOLVAY PHARM GMBH·Filed 2008·Granted May 19, 2009·0 cites·17 claims
- 0860US5576327ATreatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compoundsKALI CHEMIE PHARMA GMBH·Filed 1995·Granted Nov 19, 1996·8 cites·4 claims
- 0958US8273905B2Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivativesMOLONEY BRIAN·Filed 2009·Granted Sep 25, 2012·0 cites·13 claims
- 1057US7714150B2Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivativesSOLVAY PHARM GMBH·Filed 2006·Granted May 11, 2010·0 cites·11 claims
- 1152US6001833AUrea derivativesSOLVAY PHARM GMBH·Filed 1998·Granted Dec 14, 1999·10 cites·5 claims
- 1248US7592344B2NK1 and NK2-antagonists and compositions and methods of using the sameSOLVAY PHARM GMBH·Filed 2006·Granted Sep 22, 2009·0 cites·16 claims
- 1345US5679699A(Phenylalkylaminoalkyloxy) -heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing themKALI CHEMIE PHARMA GMBH·Filed 1995·Granted Oct 21, 1997·3 cites·6 claims
- 1444US5712283AMethod of inhibiting hyperglycemia and pharmaceutical composition for use thereinKALI CHEMIE PHARMA GMBH·Filed 1995·Granted Jan 27, 1998·10 cites·12 claims
- 1544US2007219214A1Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparationSOLVAY PHARM GMBH·Filed 2007·Application pending·0 cites
- 1638US5532251AMethod of treating cardiac arrhythmia with 3-benzoyl-3, 7-diazabicyclo[3.3.1]nonane compoundsKALI CHEMIE PHARMA GMBH·Filed 1995·Granted Jul 2, 1996·6 cites·2 claims
- 1737US5972948AMethod of inhibiting hyperglycemia and pharmaceutical composition for use thereinSOLVAY PHARM GMBH·Filed 1997·Granted Oct 26, 1999·2 cites·6 claims
- 1833US5635511ATreatment of heart rhythm disorders by administration of 3-phenylsulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds.KALI CHEMIE PHARMA GMBH·Filed 1996·Granted Jun 3, 1997·1 cites·2 claims
- 1929US6040303A7-phenyl-1, 4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 1998·Granted Mar 21, 2000·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Reinhard Brueckner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →